The role of renal dopaminergic activity in the pathophysiology of essential hypertension

Japanese Heart Journal

Volumn 37, Issue 6, 1996, Pages 815-828

  Iimura, Osamu ^a  

^a Sapporo General Hospital of Hokkaido Railway Company   (Japan)

Author keywords

Dopaminergic receptor; Essential hypertension; Family history; Renal dopaminergic activity; Urinary free dopamine

Indexed keywords

DOPAMINE; SODIUM;

ARTICLE; BODY FLUID; DOPAMINERGIC ACTIVITY; ESSENTIAL HYPERTENSION; FAMILY HISTORY; HUMAN; KIDNEY FUNCTION; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030459936     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.37.815     Document Type: Article

References (100)

1. Iimura O, Shimamoto K Salt and hypertension: Water-sodium handling in essential hypertension Ann NY Acad Sci 1993; 676: 105-21.
2. Kikuchi K, Iimura O, Moriguchi O, et al. Body fluid balance and fractional excretion of sodium, inorganic phosphorus, potassium and free water in low renin essential hypertension. Jpn Circ J 1978; 43: 882-90.
3. Iimura O, Shoji T, Okada T, et al. Sympathetic nerve activity in low renin essential hypertension. Jpn Circ J 1979; 43: 870-81.
4. Hegde SS, Jadhav AL, Lokhandwala MF. Role of kidney dopamine in the natriuretic response to volume expansion in rats. Hypertension 1989; 13: 828-34.
5. Olsen NV, Hansen JM, Ladefoged SD, Fogh-Andersen N, Leyssac PP. Renal tubular reabsorption of sodium and water during infusion of low-dose dopamine in normal man. Clin Sci 1990; 78: 503-7.
6. Bass AS, Murphy MB. Selective role of dopamine in the natriuresis produced by iso-osmotic saline infusion. Clin Exp Hypertens 1991; A13 (6&7): 1127-51.
7. Chen CJ, Lokhandwala MF. Role of endogenous dopamine in die natriuretic response to various degrees of iso-osmotic volume expansion in rats. Clin Exp Hypertens 1991; A13 (6&7): 1117-26.
8. Bell C, Mann R. Identification of dopaminergic nerves in humans. Am J Hypertens 1990; 3: 4S-6S.
9. Gluck Z, Jossen L, Weidmann P, Gnadinger MP, Peheim E. Cardiovascular and renal profile of acute peripheral dopamine 1-receptor agonism with fenoldopam. Hypertension 1987; 10: 43-54.
10. Felder CC, McKelvey AM, Gitler MS, Eisner GM, Jose PA. Dopamine receptor subtypes in renal brush border and basolateral membranes. Kidney Int 1989; 36: 183-93.
11. Amenta F, Ferrante F, Ricci A. Pharmacological characterisation and autoradiographic localisation of dopamine receptor subtypes in the cardiovascular system and in the kidney. Hypertens Res 1995; 18 Suppl. I: S23-S27.
12. Seri I. Dopamine and natriuresis: Mechanism of action and developmental aspects. Am J Hypertens 1990; 3: 82S-86S.
13. Barendregt JNM, Muizert Y, van Nispen tot Pannerden LLAM, Chang PC. Intrarenal product of dopamine and natriuresis following DOPA and saline infusions in healthy human volunteers. J Human Hypertens 1995; 9: 187-94.
14. Lee MR. Dopamine and the kidney: Ten years on. Clin Sci 1993; 84: 357-75.
15. Kuchel O. Dopamine and hypertension. Current Opinion in Cardiol 1990; 5: 594-600.
16. Baines AD. Renal nerves in the pathogenesis of hypertension: A reviw. Clin & Exper Hyper 1989; A11 (Suppl. 1): 125-32.
17. 1A) receptor gene expressed in porcine renal epithelial cells. Hypertens Res 1995; 18 Suppl. I: S11-S17.
18. Yasunari K, Kohno M, Yokokawa KL, Horio T, Kano H, Takeda T. Vascular dopamine-I receptors. Hypertens Res 1995; 18 Suppl. I: S29-S33.
19. Lackovic Z, Relja M. Evidence for a widely distributed peripheral dopaminergic system. Fed Proc 1983; 42: 3000-4
20. McDonald RH Jr, Goldberg LI, McNay JL, Tuttle EP Jr. Effect of dopamine in man: Augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest 1964; 43: 1116-24.
21. Hollenberg NK, Adams DF, Mendell P, Abrams HL, Merrill JP. Renal vascular responses to dopamine: haemodynamic and angiographic observations in normal man. Clin Sci Mol Med 1973; 45: 733-42
22. Goldberg LL, Kohli D. Peripheral pre- and post-synaptic dopamine receptors. Are they different from dopamine receptors in the central nervous system? Comm Psychopharmacol 1979; 3: 447-56.
23. Brodde O-E. Vascular dopamine receptors: Demonstration and characterization by in vitro studies. Life Sci 1982; 31: 289-306.
24. Lee MR. Dopamine and the kidney. Clin Sci 1982; 62: 439-48.
25. Bell C. Dopamine as a posiganglionic autonomic neurotransmitter. Neurosci 1982; 7: 1-8.
26. Hayashi M, Yamaji Y, Kitajima Y, Saruta T. Aromatic L-amino acid decarboxylase activity along the rat nephron. Am J Phyiol 1990; 258: F28-F33.
27. Hagege J, Richel G. Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int 1985; 27: 3-8
28. Baines AD, Chan W. Production of urine free dopamine from dopa; a micropuncture study. Life Sci 1980; 26: 253-9.
29. Stephenson RK, Sole MJ, Baines AD. Neural and extraneural catecholamine production by rat kidneys. Am J Physiol 1982; 242: F261-F266.
30. Kuchel O, Buu NT, Hamet P, Nowaczynski W, Genest J. Free and conjugated dopamine in pheochromocytoma, primary aldosteronism and essential hypertension. Hypertension 1979; 1: 267-73.
31. Smit AJ. Renal effects of exogenous and endogenous dopamine: studies on the renal haemodynamic and natriuretic effects of dopamine in man. In: Smit AJ, editor. Dopamine and the Kidney. Groningen: University of Groningen, 1988: 3-46.
32. Van Loon GR. Plasma dopamine: regulation and significance. Fed Proc 1983; 42: 3012-18.
33. Oates NS, Ball SG, Perkins CM, Lee MR. Plasma and urine dopamine in man given sodium chloride. Clin Sci 1979; 56: 261-4.
34. Ball SG, Oates NS, Lee MR. Urinary dopamine in man and rat: effect of inorganic salts on dopamine excretion. Clin Sci Mol Med 1978; 55: 167-73.
35. Goldstein M, Fuxe K, Hokfelt T. Characterization and tissue localization of catecholamine syndiesizing enzymes. Pharmacol Rev 1972; 24: 293-309.
36. Dinerstein RJ, Vannice J, Henderson RC, Roth LJ, Goldberg LJ, Hoffmann PC. Histofluorescence techniques provide evidence for dopamine-containing neuronal elements in canine kidney. Science 1979; 205: 497-9.
37. Aperia A, Hokfelt T, Meister B, et al The significance of L-amino acid decarboxylase and DDARPP-32 in the kidney. Am J Hypertens 1990; 3: 11S-13S.
38. + antiport activity in rat renal cortical brush border membrane vesicles. Clin & Exp Hyper 1992; A41: 653-66.
39. +-ATPase activity in rat proximal convoluted tubule segment. Am J Physiol 1987; 252: F39-F45.
40. Lokhandwala MF, Kansra V, Chen C. Dopaminergic modulation of Na, K-ATPase activity in the proximal tubules of normotensive and hypertensive rats. Hypertens Res 1995; 18 Suppl. I: S43-S46.
41. 1 agonist, fenoldopam, used alone or in combination with dopamine and dobutamine. Circulation 1988; 78: 1310-5
42. Felder CC, Albreht F, Eisner GM, Jose PA. The signal transducer for the dopamine-1 regulated sodium transport in renal cortical brush border membrane vesicles. Am J Hypertens 1990; 3: 47S-50S.
43. Hegde SS, Lokhandwala MF. Renal dopamine and sodium excretion. Am J Hypertens 1990; 3: 78S-81S.
44. Richet G, Wahbe F, Hagege J, Wiemeyer W. Extraneural production of dopamine by kidney sliced in normo and hypertensive rats. Clin & Exper Hyper 1987; A9 (Suppl. 1): 127-34.
45. Barthelmebs M, Vailly B, Velly J, Erhardt JD, Grima M, Imbs JL. Renal dopamine synthesis from precursors. Am J Hypertens 1990; 3: 18S-21S.
46. Alexander RW, Gill JR, Yamabe H, Lovenberg W, Keiser HR. Effects of dietary sodium and of acute saline infusion on the interrelationship between dopamine excretion and adrenergic activity in man. J Clin Invest 1974; 54: 194-200.
47. Carey RM, Van Loon GR, Baines AD, Ortt EM. Decreased plasma and urinary dopamine during dietary sodium depletion in man. J Clin Endocrinol Metab 1981; 52: 903-9.
48. Yoshimura M, Yamazaki H, Takashima R, et al. The significance of duration of salt loading on cardiovascular response and urinary excretion of catecholamine in rats. Endocrinol Jpn 1986; 33: 169-75.
49. Goldstein DS, Stull R, Eisenhofer G, Gill JR, Jr. Urinary excretion of dihydroxyphenylalanine and dopamine during alterations of dietary salt intake in humans. Clin Sci 1989; 76: 517-22.
50. Bass AS, Murphy MB. Role of endogenous dopamine in the natriuresis accompanying various sodium challenges. Am J Hypertens 1990; 3: 90S-92S
51. Young JB. Regulation of urinary dopamine by protein and NaCl. Am J Hypertens 1990; 3: 14S-17S
52. Baines AD. Effects of salt intake and renal denervation on catecholamine catabolism and excretion. Kidney Int 1982; 21: 316-22.
53. Bradley T, Hjemdahl P. Further studies on renal nerve stimulation induced release of noradrenaline and dopamine from the canine kidney in situ. Acta Physiol Scand 1984; 122: 369-79.
54. Stoof JC, Kebabian JW. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci 1984; 35: 2281-96.
55. Goldberg LI, Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol Rev 1972; 24: 1-29.
56. Kohli JD, McNay JL, Rajfer SI, Murphy MB. Peripheral dopamine receptors in cardiovascular therapy. The legacy of Leon Goldberg (1927-1989). Hypertension 1991; 17: 700-6.
57. 3H] Sch 23390. Am J Physiol 1989; 257: F414-F423.
58. Sidhu A, Felder RA, Jose PA, Fishman PH. Comparison of the central and renal dopamine-1 receptor. Am J Hypertens 1990; 3: 37S.
59. Goldberg LI. Dopamine receptor subtypes and hypertension. Clin & Exper Hyper 1987; A9: 833-6.
60. 1 receptor agonist (fenoldopam) in patients with congestive heart failure. Am Heart J 1988; 116: 473-9.
61. Hughes JM, Ragsdale NV, Felder RA, Chevalier RL, King B, Carey RM. Diuresis and natriuresis during continuous dopamine-1 receptor stimulation. Hypertension 1988; 11 [Suppl I]: I-69-I-74.
62. Ragsdale NV, Lynd M, Chevalier RL, Felder RA, Peach MJ, Carey RM. Selective peripheral dopamine-1 receptor stimulation. Differential responses to sodium loading and depletion in humans. Hupertension 1990; 15: 914-21.
63. 2-adrenergic receptors and hypertension. Hypertension 1987; 9: 3-6.
64. Ganguly A. Dopaminergic regulation of aldosterone secretion: How credible? Clin Sci 1984; 66: 631-7.
65. Witzgall H, Lorenz R, von Werder K, Weber PC. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism. Clin Sci 1985; 68: 291-9.
66. Carey RM, Drake CR, Jr. Dopamine selectively inhibits aldosterone response to angiotensin II in humans. Hypertension 1986; 8: 399-406.
67. Mannelli M, Pupilli C, Fabbri G, et al. Endogenous dopamine (DA) and DA2 receptors: A mechanism limiting excessive sympathetic-adrenal discharge in humans. J Clin Endocrinol Metab 1988; 66: 626-31.
68. Hughes JM, Beck TR, Rose CE, Jr, Carey RM. The effect of selective dopamine-1 receptor stimulation on renal and adrenal function in man. J Clin Endocrinol Metab 1988; 66: 518-25.
69. Yamaguchi I, Walk SF, Felder RA. Studying the dopaminergic system with transfected receptors. Hypertens Res 1995; 18 Suppl. I: S19-S22.
70. Bates MD, Gingrich JA, Bunzow JR, et al. Molecular characterization of dopamine receptors. Am J Hypertens 1990; 3: 29S-33S.
71. Shultz PJ, Sedor JR, Abboud HE. Dopaminergic stimulation of cAMP accumulation in cultured rat mesangial cells. Am J Physiol 1987; 253: H358-H364.
72. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 1989; 84: 1849-56.
73. Schoors DF, Dupont AG. Increased dopamine-induced nephrogenous cAMP formation in hypertension. Am J Hypertens 1991; 4: 494-9.
74. 1 receptor regulation of Phospholipase C. Hypertens Res 1995; 18 Suppl. I: S39-S42.
75. Felder RA, Felder CC, Eisner GM, Jose AP. The dopamine receptor in adult and maturing kidney. Am J Physiol 1989; 257: F315-F327.
76. Iimura O, Yamaji I, Kikuchi K, et al. The pathophysiological role of renal dopaminergic activity in patients with essential hypertension Jpn Circ J 1987; 51: 1232-40.
77. Serrano PA, Figueroa G, Torres ZM, Del Angel AR. Adrenaline, noradrenaline and dopamine excretion in patients with essential hypertension. Am J Cardiol 1964; 13: 484-8.
78. Aoki K, Kikuchi K, Yamaji I, et al. Attenuated renal production of dopamine in patients with low renin essential hypertension. Clin & Exper Hyper 1989; A11 (Suppl. 1): 403-9.
79. Lee MR. Dopamine, the kidney and essential hypertension. Clin & Exper Hyper 1989: A11 (Suppl. 1): 149-58
80. Kikuchi K, Iimura O, Yamaji I, et al. The pathophysiological role of water-sodium balance and renal dopaminergic activity in overweight patients with essential hypertension. J Clin Hypertens 1987; 3: 3-11.
81. Kuchel OG, Kuchel GA. Peripheral dopamine in pathophysiology of hypertension. Interaction with aging and lifestyle. Hypertension 1991; 18: 709-21.
82. Arakawa K, Miura S, Koga M, Kinoshita A, Urata H, Kiyonaga A. Activation of renal dopamine system by physical exercise. Hypertens Res 1995; 18 Suppl. I: S73-S77.
83. Shigetomi S, Yamada Z, Ishii H, Sanada H, Watanabe H, Fukuchi S. Dopaminergic activity and endorenal dopamine synthesis in non-insulin dependent diabetes mellitus. Hypertens Res 1995; 18 Suppl. I: S125-S130.
84. 3H-dopamine radiotracer technique as an index of renal dopaminergic nerve activity. Hypertens Res 1995; 18 Suppl. I: S145-S146.
85. Nishimura M, Takahashi H, Nanbu A, et al. Urinary excretion of free dopamine and digoxinlike substances correlates with endogenous secretion of insulin in normotensive adults, but not in hypertensive subjects Hypertens Res 1995; 18 Suppl. I: S191-S192.
86. Finlay GD, Whitsett TL, Cucinell EA, Goldberg LI. Augmentation of sodium and potassium excretion, glomerular filtration rate and renal plasma flow by levodopa. N Engl J Med 1971; 284: 867-70.
87. Kikuchi K, Miyama A, Nakao T, et al. Hemodynamic and natriuretic response to intravenous infusion of dopamine in patients with essential hypertension. Jpn Circ J 1982; 46: 486-93.
88. Iimura O, Kikuchi K, Takigami Y, Mito T, Tsuzuki M, Shibata S. Enhanced natriuretic response to dopamine infusion in low renin essential hypertension New Zeal Med J 1983; 96: 860-3.
89. Worth DP, Harvey JN, Brown J, Lee MR. Patients with essential hypertension have an exaggerated natnuretic response to the dopamine pro-drug glutamyl-dopa. J Hypertens 1985; 3 (Suppl 3): S179-S181.
90. Andrejak M, Hary L. Enhanced dopamine renal responsiveness in patients with hypertension. Clin Pharmacol Ther 40: 610, 1986.
91. Clark BA, Rosa RM, Epstein FH, Young JB, Landsberg L. Altered dopaminergic responses in hypertension. Hypertension 1992; 19: 589-94.
92. Kuchel O, Shigetomi S. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients. Hypertension 1992; 19: 634-8.
93. Gill JR, Grossman E, Goldstein DS. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Hypertension 1991; 18: 614-21.
94. Iimura O, Shimamoto K, Ura N, Dopaminergic activity and water-sodium handling in the kidneys of essential hypertensive subjects: is renal dopaminergic activity suppressed at the prehypertensive stage? J Cardiovasc Pharmacol 1990; 16 (Suppl. 7): S56-S58.
95. Iimura O, Shimamoto K. Suppressed dopaminergic activity and water-sodium handling in the kidneys at the prehypertensive stage of essential hypertension. J Auton Pharmacol 1990; 10 Suppl 1: s73-77.
96. Muldoon MF, Terrell DF, Bunker CH, Manuck SB. Family history studies in hypertension research. Review of the literature. Am J Hypertens 1993; 6: 76-88.
97. Shimamoto K, Ura N, Nishimura M, Iimura O. Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension. Am J Med Sci 1994; 307 (Suppl 1): S70-S74.
98. Katoh T, Sophasan S, Kurokawa K. Permissive role of dopamine in renal action of ANP in volume-expanded rats. Am J Physiol 1989; 257: F300-F309.
99. Felder RA, Seikaly MG, Cody P, Eisner GM, Jose PA. Attenuated renal response to dopaminergic drugs in spontaneously hypertensive rats. Hypertension 1990; 15: 560-9.
100. Shimamoto K, Ura N, Ishiguro T, Nakagawa M, Iimura O. The role of renal natriuretic depressor system on hypertensive mechanisms in reduced renal mass hypertensive rats. Hypertens Res 1995; 18 Suppl. I: S53-7